CasePit
AAPLTSLAMSFTNVDAAMZNGOOGLMETAAMDNFLXPLTRCOINJPM
AAPLTSLAMSFTNVDAAMZNGOOGLMETAAMDNFLXPLTRCOINJPM
Post DDLog in
  • Feed
  • Discover
  • Watchlist
  • Messages
  • Profile

Verify your position

Show a βœ“ badge on your posts. Proof beats opinion.

Add a position

Trending now

Promoted

Something missing?

s/wishlist is where features get requested, argued over, and built.

Open s/wishlist β†’

Not financial advice. Prices are delayed. Verified positions reflect a point-in-time check, not current holdings.

CasePit is a community discussion platform. Nothing here is financial advice, an offer, or a recommendation to buy or sell any security. Verified positions show what a member held at the time of verification, not what they hold now. Prices are delayed and provided for information only. Do your own research.

πŸ“± CasePit for iOS is in the works.

  • About
  • Congress
  • Insiders
  • Terms of Service
  • Privacy Policy
  • Risk Notice
  • Imprint
  • Moderation notices
  • Feed
  • Discover
  • +
  • Watchlist
  • Profile

EMR

Emerson Electric Company

Open
High
Low
Prev close
Volume

About Emerson Electric Company

Emerson Electric Company (EMR) is a Technology company in the Electronic & Other Electrical Equipment (No Computer Equip) industry with a market capitalisation of $90.4B. The stock trades at 35.25x trailing earnings and yields 1.38%.

Sector
Technology
Industry
Electronic & Other Electrical Equipment (No Computer Equip)
Market cap
$90.4B
P/E ratio
35.25
EPS (TTM)
$4.04
Revenue (TTM)
$18B
Free cash flow
$2.7B
Profit margin
12.7%
Dividend yield
1.38%
Shares outstanding
557.8M

Financial health: Strong8/10

7 strengths, 1 concern. Weakest points: current ratio.

  • Debt to equity: 0.44 (Strong, benchmark < 0.5) β€” Debt of 0.44x equity is conservative against the 0.5x benchmark. It has improved over the last 4 years.
  • Net debt vs cash flow: 2.8y (Strong, benchmark < 4 years) β€” Net debt of $7.4B is 2.8x annual free cash flow β€” about 3 years of cash flow to repay.
  • Current ratio: 0.88 (Concern, benchmark > 1.5) β€” Short-term assets cover only 0.88x short-term liabilities β€” below 1.0, meaning bills due this year exceed the assets on hand to pay them. It has deteriorated over the last 4 years.
  • Return on equity: 11.3% (Watch, benchmark > 15%) β€” Earns 11.3% on shareholder equity, short of the > 15% mark.
  • Gross margin: 52.8% (Strong, benchmark > 40%) β€” Keeps 52.8% of revenue after the direct cost of sales, comfortably past the > 40% mark.
  • Net margin: 12.7% (Strong, benchmark > 10%) β€” Turns 12.7% of revenue into profit, comfortably past the > 10% mark.
  • Free cash flow: $2.7B (Strong, benchmark positive) β€” Generated $2.7B of free cash flow after capital spending. It has been broadly flat over the last 4 years.
  • Revenue growth: 3.0% (Watch, benchmark > 10%) β€” Revenue changed 3.0% year on year, short of the > 10% mark.
  • Earnings growth: 16.5% (Strong, benchmark > 10%) β€” Earnings changed 16.5% year on year, comfortably past the > 10% mark.
  • Payout ratio: 52.0% (Strong, benchmark < 60%) β€” Pays out 52.0% of earnings as dividends, leaving room to keep paying.

AI take

AI-generated Β· not financial advice

EMR news

Promoted

Something missing?

s/wishlist is where features get requested, argued over, and built.

Open s/wishlist β†’

Discussion in s/EMR